- •Foreword
- •Preface
- •Contributors
- •Contents
- •1. Epidemiology of Pediatric Strabismus
- •1.1 Introduction
- •1.2 Forms of Pediatric Strabismus
- •1.2.1 Esodeviations
- •1.2.1.1 Congenital Esotropia
- •1.2.1.2 Accommodative Esotropia
- •1.2.1.3 Acquired Nonaccommodative Esotropia
- •1.2.1.4 Abnormal Central Nervous System Esotropia
- •1.2.1.5 Sensory Esotropia
- •1.2.2 Exodeviations
- •1.2.2.1 Intermittent Exotropia
- •1.2.2.2 Congenital Exotropia
- •1.2.2.4 Abnormal Central Nervous System Exotropia
- •1.2.2.5 Sensory Exotropia
- •1.2.3 Hyperdeviations
- •1.3 Strabismus and Associated Conditions
- •1.4.1 Changes in Strabismus Prevalence
- •1.4.2 Changes in Strabismus Surgery Rates
- •1.5 Worldwide Incidence and Prevalence of Childhood Strabismus
- •1.6 Incidence of Adult Strabismus
- •References
- •2.1 Binocular Alignment System
- •2.1.2 Vergence Adaptation
- •2.1.3 Muscle Length Adaptation
- •2.2 Modeling the Binocular Alignment Control System
- •2.2.1 Breakdown of the Binocular Alignment Control System
- •2.2.4 Changes in Basic Muscle Length
- •2.2.6 Evidence Against the “Final Common Pathway”
- •2.3 Changes in Strabismus
- •2.3.1 Diagnostic Occlusion: And the Hazard of Prolonged Occlusion
- •2.3.2.1 Supporting Evidence for Bilateral Feedback Control of Muscle Lengths
- •2.4 Applications of Bilateral Feedback Control to Clinical Practice and to Future Research
- •References
- •3.1 Dissociated Eye Movements
- •3.2 Tonus and its relationship to infantile esotropia
- •3.5 Pathogenetic Role of Dissociated Eye Movements in Infantile Esotropia
- •References
- •4.1 Introduction
- •4.2.1 Binocular Correspondence: Anomalous, Normal, or Both?
- •4.3 MFS with Manifest Strabismus
- •4.3.1 Esotropia is the Most Common Form of MFS
- •4.3.2 Esotropia Allows for Better Binocular Vision
- •4.3.3 Esotropia is the Most Stable Form
- •4.4 Repairing and Producing MFS
- •4.4.1 Animal Models for the Study of MFS
- •References
- •5.1 Esotropia as the Major Type of Developmental Strabismus
- •5.1.2 Early Cerebral Damage as the Major Risk Factor
- •5.1.3 Cytotoxic Insults to Cerebral Fibers
- •5.1.5 Development of Binocular Visuomotor Behavior in Normal Infants
- •5.1.6 Development of Sensorial Fusion and Stereopsis
- •5.1.7 Development of Fusional Vergence and an Innate Convergence Bias
- •5.1.8 Development of Motion Sensitivity and Conjugate Eye Tracking (Pursuit/OKN)
- •5.1.9 Development and Maldevelopment of Cortical Binocular Connections
- •5.1.10 Binocular Connections Join Monocular Compartments Within Area V1 (Striate Cortex)
- •5.1.11 Too Few Cortical Binocular Connections in Strabismic Primate
- •5.1.12 Projections from Striate Cortex (Area V1) to Extrastriate Cortex (Areas MT/MST)
- •5.1.15 Persistent Nasalward Visuomotor Biases in Strabismic Primate
- •5.1.16 Repair of Strabismic Human Infants: The Historical Controversy
- •5.1.18 Timely Restoraion of Correlated Binocular Input: The Key to Repair
- •References
- •6. Neuroanatomical Strabismus
- •6.1 General Etiologies of Strabismus
- •6.2 Extraocular Myopathy
- •6.2.1 Primary EOM Myopathy
- •6.2.2 Immune Myopathy
- •6.2.4 Neoplastic Myositis
- •6.2.5 Traumatic Myopathy
- •6.3 Congenital Pulley Heterotopy
- •6.4 Acquired Pulley Heterotopy
- •6.5 “Divergence Paralysis” Esotropia
- •6.5.1 Vertical Strabismus Due to Sagging Eye Syndrome
- •6.5.2 Postsurgical and Traumatic Pulley Heterotopy
- •6.5.3 Axial High Myopia
- •6.6 Congenital Peripheral Neuropathy: The Congenital Cranial Dysinnervation Disorders (CCDDs)
- •6.6.1 Congenital Oculomotor (CN3) Palsy
- •6.6.3 Congenital Trochlear (CN4) Palsy
- •6.6.4 Duane’s Retraction Syndrome (DRS)
- •6.6.5 Moebius Syndrome
- •6.7 Acquired Motor Neuropathy
- •6.7.1 Oculomotor Palsy
- •6.7.2 Trochlear Palsy
- •6.7.3 Abducens Palsy
- •6.7.4 Inferior Oblique (IO) Palsy
- •6.8 Central Abnormalities of Vergence and Gaze
- •6.8.1 Developmental Esotropia and Exotropia
- •6.8.2 Cerebellar Disease
- •6.8.3 Horizontal Gaze Palsy and Progressive Scoliosis
- •References
- •7.1 Congenital Cranial Dysinnervation Disorders: Facts About Ocular Motility Disorders
- •7.1.1 The Concept of CCDDs: Ocular Motility Disorders as Neurodevelopmental Defects
- •7.1.1.1 Brainstem and Cranial Nerve Development
- •7.1.1.2 Single Disorders Representing CCDDs
- •7.1.1.3 Disorders Understood as CCDDs
- •7.2 Congenital Cranial Dysinnervation Disorders: Perspectives to Understand Ocular Motility Disorders
- •7.2.1.1 Brown Syndrome
- •Motility Findings
- •Saccadic Eye Movements
- •Comorbidity
- •Epidemiologic Features
- •Laterality
- •Sex Distribution
- •Incidence
- •Heredity
- •Potential Induction of the Syndrome
- •Radiologic Findings
- •Natural Course in Brown Syndrome
- •Intra-and Postoperative Findings
- •References
- •8.1 Amblyopia
- •8.2 What Is Screening?
- •8.2.1 Screening for Amblyopia, Strabismus, and/or Refractive Errors
- •8.2.1.1 Screening for Amblyopia
- •8.2.1.2 Screening for Strabismus
- •8.2.1.3 Screening for Refractive Error
- •8.2.1.4 Screening for Other Ocular Conditions
- •8.3 Screening Tests for Amblyopia, Strabismus, and/or Refractive Error
- •8.3.1 Vision Tests
- •8.3.3 Stereoacuity
- •8.3.4 Photoscreening and/or Autorefraction
- •8.3.6 Who Should Administer the Screening Program?
- •8.4 Treatment of Amblyopia
- •8.4.1 Type of Treatment
- •8.4.2 Refractive Adaptation
- •8.4.3 Conventional Occlusion
- •8.4.4 Pharmacological Occlusion
- •8.4.5 Optical Penalization
- •8.4.7 Treatment Compliance
- •8.4.8 Other Treatment Options for Amblyopia
- •8.4.9 Recurrence of Amblyopia Following Therapy
- •8.5 Quality of Life
- •8.5.1 The Impact of Amblyopia Upon HRQoL
- •8.5.3 Reading Speed and Reading Ability in Children with Amblyopia
- •8.5.4 Impact of Amblyopia Upon Education
- •8.5.6 The Impact of Strabismus Upon HRQoL
- •8.5.7 Critique of HRQoL Issues in Amblyopia
- •8.5.8 The Impact of the Condition or the Impact of Treatment?
- •References
- •9. The Brückner Test Revisited
- •9.1 Amblyopia and Amblyogenic Disorders
- •9.1.1 Early Detection of Amblyopia
- •9.1.2 Brückner’s Original Description
- •9.2.1 Physiology
- •9.2.2 Performance
- •9.2.3 Shortcomings and Pitfalls
- •9.3.1 Physiology
- •9.3.2 Performance
- •9.3.3 Possibilities and Limitations
- •9.4.1 Physiology
- •9.4.2 Performance
- •9.4.3 Possibilities and Limitations
- •9.5 Eye Movements with Alternating Illumination of the Pupils
- •References
- •10. Amblyopia Treatment 2009
- •10.1 Amblyopia Treatment 2009
- •10.1.1 Introduction
- •10.1.2 Epidemiology
- •10.1.3 Clinical Features of Amblyopia
- •10.1.4 Diagnosis of Amblyopia
- •10.1.5 Natural History
- •10.2 Amblyopia Management
- •10.2.1 Refractive Correction
- •10.2.2 Occlusion by Patching
- •10.2.3 Pharmacological Treatment with Atropine
- •10.2.4 Pharmacological Therapy Combined with a Plano Lens
- •10.3 Other Treatment Issues
- •10.3.1 Bilateral Refractive Amblyopia
- •10.3.3 Maintenance Therapy
- •10.4 Other Treatments
- •10.4.1 Filters
- •10.4.2 Levodopa/Carbidopa Adjunctive Therapy
- •10.5 Controversy
- •10.5.1 Optic Neuropathy Rather than Amblyopia
- •References
- •11.1 Introduction
- •11.1.2 Sensory or Motor Etiology
- •11.1.4 History
- •11.1.5 Outcome Parameters
- •11.2 Outcome of Surgery in the ELISSS
- •11.2.1 Reasons for the ELISSS
- •11.2.2 Summarized Methods of the ELISSS
- •11.2.3 Summarized Results of the ELISSS
- •11.2.4 Binocular Vision at Age Six
- •11.2.5 Horizontal Angle of Strabismus at Age Six
- •11.2.6 Alignment is Associated with Binocular Vision
- •11.3 Number of Operations and Spontaneous Reduction into Microstrabismus Without Surgery
- •11.3.1 The Number of Operations Per Child and the Reoperation Rate in the ELISSS
- •11.3.2 Reported Reoperation Rates
- •11.3.3 Test-Retest Reliability Studies
- •11.3.6 Spontaneous Reduction of the Angle
- •11.3.7 Predictors of Spontaneous Reduction into Microstrabismus
- •Appendix
- •References
- •12.1 Overview
- •12.1.2 Manifest Latent Nystagmus (MLN)
- •12.1.2.1 Clinical Characteristics of Manifest Latent Nystagmus (MLN)
- •12.1.3 Congenital Periodic Alternating Nystagmus (PAN)
- •12.1.3.1 Clinical characteristics of congenital periodic alternating nystagmus
- •12.2 Compensatory Mechanisms
- •12.2.1 Dampening by Versions
- •12.2.2 Dampening by Vergence
- •12.2.3 Anomalous Head Posture (AHP)
- •12.2.3.4 Measurement of AHP
- •12.2.3.6 Testing AHP at Near
- •12.3 Treatment
- •12.3.1 Optical Treatment
- •12.3.1.1 Refractive Correction
- •12.3.1.2 Spectacles and Contact Lenses (CL)
- •12.3.1.3 Prisms
- •12.3.1.4 Low Visual Aids
- •12.3.2 Medication
- •12.3.3 Acupuncture
- •12.3.4 Biofeedback
- •12.3.6 Surgical Treatment of Congenital Nystagmus
- •12.3.6.1 Management of Horizontal AHP
- •12.3.6.2 Management of Vertical AHP
- •12.3.6.3 Management of Head Tilt
- •Retro-Equatorial Recession of Horizontal Rectus Muscles
- •The Tenotomy Procedure
- •References
- •13.1 Dissociated Deviations
- •13.2 Surgical Alternatives to Treat Patients with DVD
- •13.2.1 Symmetric DVD with Good Bilateral Visual Acuity, with No Oblique Muscles Dysfunction
- •13.2.2 Bilateral DVD with Deep Unilateral Amblyopia
- •13.2.3 DVD with Inferior Oblique Overaction (IOOA) and V Pattern
- •13.2.4 DVD with Superior Oblique Overaction (SOOA) and A Pattern
- •13.2.5 Symmetric vs. Asymmetric Surgeries for DVD
- •13.3 Dissociated Horizontal Deviation
- •13.4 Dissociated Torsional Deviation. Head tilts in patients with Dissociated Strabismus
- •13.5 Conclusions
- •References
- •14.1 Introduction
- •14.2 Clinical and Theoretical Investigations
- •References
- •15.1 General Principles of Surgical Treatment in Paralytic Strabismus
- •15.1.1 Aims of Treatment
- •15.1.2 Timing of Surgery
- •15.1.3 Preoperative Assessment
- •15.1.4 Methods of Surgical Treatment
- •15.2 Third Nerve Palsy
- •15.2.1 Complete Third Nerve Palsy
- •15.2.2 Incomplete Third Nerve Palsy
- •15.3 Fourth Nerve Palsy
- •15.4 Sixth Nerve Palsy
- •References
- •16.1 Graves Orbitopathy (GO): Pathogenesis and Clinical Signs
- •16.1.1 Graves Orbitopathy is Part of a Systemic Disease: Graves Disease (GD)
- •16.1.2 Graves Orbitopathy−Clinical Signs
- •16.1.2.1 Clinical Changes Result in Typical Symptoms
- •16.1.3 Clinical Examination of GO
- •16.1.3.1 Signs of Activity
- •16.1.3.2 Assessing Severity of GO
- •16.1.3.3 Imaging
- •16.2 Natural History
- •16.3 Treatment of GO
- •16.3.1.1 Glucocorticoid Treatment
- •16.3.1.2 Orbital Radiotherapy
- •16.3.1.3 Combined Therapy: Glucocorticoids and Orbital Radiotherapy
- •16.3.1.4 Other Immunosuppressive Treatments and New Developments
- •16.3.2 Inactive Disease Stages
- •16.3.2.1 Orbital Decompression
- •16.3.2.2 Extraocular Muscle Surgery
- •16.3.2.3 Lid Surgery
- •16.4 Thyroid Dysfunction and GO
- •16.5.1 Relationship Between Cigarette Smoking and Graves Orbitopathy
- •16.5.2 Genetic Susceptibility
- •16.6 Special Situations
- •16.6.1 Euthyroid GO
- •16.6.2 Childhood GO
- •16.6.3 GO and Diabetes
- •References
The clinical findings seem consistent, future studies namely genetic studies in familial cases or on candidate genes will help to test this model.
Summary for the Clinician
■Congenital Brown syndrome, congenital monocular elevation deficiency and vertical retraction syndrome as nonprogressive forms of strabismus with fibrotic changes share features with CCDDs and are found to be accompanied intraindividually or familial by other CCDDs.
■Electromyographic, neuroradiologic and surgical findings support the hypothesis that Brown syndrome represents a CCDD.
■Genetic linkage analysis or examination of candidate genes might prove or disprove a model that hypothesizes a continuous spectrum of congenital neurodevelopmental elevation disorders.
Acknowledgment The data of our own Brown syndrome [103] series and the literature on this topic as discussed in chapter 7.2.1.1 were evaluated in cooperation with Gregor Schaaf.
References
1.Breinin GM (1957) Electromyography: a tool in ocular and neurologic diagnosis. II. Muscle palsy. Arch Ophthalmol 57:165–175
2.Engle EC (2007) Oculomotility disorders arising from disruptions in brainstem motor neuron development. Arch Neurol 64(5):633–637
3.Engle EC, Leigh RJ (2002) Genes, brainstem development, and eye movements. Neurology 59(3):304–305
4.Hotchkiss MG, Miller NR, Clark AW, et al (1980) Bilateral Duane’s retraction syndrome. A clinical-pathologic case report. Arch Ophtalmol 98:870–874
5.Huber A, Esslen E (1969) Duane’s syndrome; observations on the pathogenesis and etiology of di erent formes of the Stilling-Duane-Turk-retraction syndrome. Doc Ophthalmol 26:619–628
6.Kohlhase J, Heinrich M, Schubert L, Liebers M, et al (2002) Okihiro syndrome is caused by SALL4 mutations. Hum Mol Genet 11(23):2979–2987
7.Miller NR (2005) Strabismus syndromes: the congenital cranial dysinnervation disorders (CCDDs). In: Taylor D, Hoyt CS (eds) Pediatric ophthalmology and strabismus. Elsevier, Saunders, Edinburgh, London
References 91
8.Miller NR, Kiel SM, Green WR, et al (1982) Unilateral Duane’s retraction syndrome (TypI). Arch Ophthalmol 100(9):1468–1472
9.Brown HW (1950) Congenital structural muscle anomalies. In: Allen JH (ed) Strabismus ophthalmic symposium I. VC Mosby, St. Louis
10.Al-Baradie R, Yamada K, St Hilaire C, et al (2002) Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SALL family. Am J Hum Genet 71(5):1195–1199 Epub 2002 Oct 22
11.Engle EC (2002) Applications of molecular genetics to the understanding of congenital ocular motility disorders. Ann N Y Acad Sci 956:55–63
12.Engle EC (2006) The genetic basis of complex strabismus. Pediatr Res 59(3):343–348
13.Engle EC (2007) Genetic basis of congenital strabismus. Arch Ophthalmol 125(2):189–195
14.Engle EC, Goumnerov BC, McKeown CA, et al (1997) Oculomotor nerve and muscle abnormalities in congenital fibrosis of the extraocular muscles. Ann Neurol 41(3): 314–325
15.Jen JC, Chan WM, Bosley TM, et al (2004) Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. Science 304(5676):1509–1513. Epub 2004 Apr 22
16.Gutowski NJ, Bosley TM, Engle EC (2003) The congenital cranial dysinnervation disorders. Neuromuscul Disord 13:573–578
17.Hans ten Donkelaar J, Lammens M, Hori A (2006) Clinical neuroembryology. Springer, Berlin
18.Purves D (ed) (2008) Neuroscience, 4th edn. Sinauer Associates, Massachusetts
19.Sanes DH (ed) (2006) Development of the nervous system, 2nd edn. Elsevier, Amsterdam
20.Woods CG (2004) Crossing the Midline. Science 304: 1455–1456
21.Nakano M, Yamada K, Fain J, et al (2001) Homozygous mutations in ARIX(PHOX2A) result in congenital fibrosis of the extraocular muscles type 2. Nat Genet 29(3): 315–320
22.Yamada K, Andrews C, Chan WM, et al (2003) Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1). Nat Genet 35(4):318–321. Epub 2003 Nov 2
23.Miyake N, Chilton J, Psatha M, et al (2008) Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane’s retraction syndrome. Science 321(5890):839–843. Epub 2008 Jul 24
24.Tischfield MA, Bosley TM, Salih MA (2005) Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development. Nat Genet 37 (10):1035–1037. Epub 2005 Sep 11
927 Congenital Cranial Dysinnervation Disorders: Facts and Perspectives
25.Heuck G (1879) Über angeborenen vererbten Beweglich41. Bosley TM, Alorainy IA, Salih MA, et al (2008) The clinical
keitsdefect der Augen. Klin Monatsbl Augenheilkd 17: 253–278
26. Brodsky MC, Pollock SC, Buckley EG (1989) Neural
7misdirection in congenital ocular fibrosis syndrome: implications and pathogenesis. Pediatr Ophthalmol Strabismus 26(4):159–161
27.Cibis GW (1984) Congenital familial external ophthalmoplegia with co-contraction. Ophthalmic Paediatr Genet 4:163–167
28.Yamada K, Hunter DG, Andrews C, et al (2005) A novel KIF21A mutation in a patient with congenital fibrosis of the extraocular muscles and Marcus Gunn jaw-winking phenomenon. Arch Ophthalmol 123(9):1254–1259
29.Heidary G, Engle EC, Hunter DG (2008) Congenital fibrosis of the extraocular muscles. Semin Ophthalmol 23(1):3–8
30.Yazdani A, Chung DC, Abbaszadegan, et al (2005) A novel PHOX2A/ARIX mutation in an Iranian family with congenital fibrosis of extraocular muscles type 2 (CFEOM2). Am J Ophthalmol 136(5):861–865
31.Hanisch F, Bau V, Zierz S (2005) Congenital fibrosis of extraocular muscles (CFEOM) and other phenotypes of congenital cranial dysinnervation syndromes (CCDD). Nervenarzt 76(4):395–402
32.Yamada K,ChanWM,Andrews C,et al (2004) Identification of KIF21A mutations as a rare cause of congenital fibrosis of the extraocular muscles type 3 (CFEOM3). Invest Ophthalmol Vis Sci 45(7):2218–2223
33.Duane A (1905) Congenital deficiency of abduction, associated with impairment of adduction, retraction movements, contraction of the palpebral fissure and oblique movements of the eye. Arch Ophthalmol 34:139–159
34.De Respinis PA, Caputo AR,Wagner RS, et al (1993) Duane’s retraction syndrome. Surv Ophthalmol 38: 257–288
35.Kim HJ, Hwang JM (2005) Presence of the abducens nerve according to the type of Duane’s retraction syndrome. Ophthalmology 112(1):109–113
36.Ozkurt H, Basak M, Oral Y, et al (2003) Magnetic resonance imaging in Duane’s retraction syndrome. J Pediatr Ophthalmol Strabismus 40(1):19–22
37.Parsa CF, Grant E, Dillon WP Jr (1998) Absence of the abducens nerve in Duane syndrome verified by magnetic resonance imaging. Am J Ophthalmol 125(3):399–401
38.Tischfield MA, Chan WM, Grunert JF, et al (2006) HOXA1 mutations are not a common cause of Duane anomaly. Am J Med Genet A 140(8):900–902
39.Wabbels BK, Lorenz B, Kohlhase J (2004) No evidence of SALL4-mutations in isolated sporadic duane retraction “syndrome” (DURS). Am J Med Genet A 131(2):216–218
40.Bosley TM, Salih MA, Alorainy IA, et al (2007) Clinical characterization of the HOXA1 syndrome BSAS variant. Neurology 69(12):1245–1253
spectrum of homozygous HOXA1 mutations. Am J Med Genet A 146A(10):1235–1240
42.Holve S, Friedman B, Hoyme HE, et al (2003) Athabascan brainstem dysgenesis syndrome. Am J Med Genet A 120A(2):169–173
43.Stein HJ, Papst W (1969) Elektromyographische Untersuchungen zur Pathogenese und Therapie des Musculus obliquus superior-Sehnenscheidensyndroms (BrownSyndrom). Ber Zusammenkunft Dtsch Ophthalmol Ges 69:618–624
44.Wegmeyer H,Egea J,Rabe N,et al (2007) EphA4-dependent axon guidance is mediated by the RacGAP a2-Chimaerin. Neuron 55:756–767
45.Chan WM, Traboulsi EI, Arthur B, et al (2006) Horizontal gaze palsy with progressive scoliosis can result from compound heterozygous mutations in ROBO3. J Med Genet 43(3):e11
46.Haller S, Wetzel SG, Lütschg J (2008) Functional MRI, DTI and neurophysiology in horizontal gaze palsy with progressive scoliosis. Neuroradiology 50:453–459
47.Pieh C, Lagrèze WA (2007) Angeborene Fehlinnervationssyndrome. Ophthalmologe 104:1083–1096
48.Sicotte NL, Salamon G, Shattuck DW, et al (2006) Di usion tensor MRI shows abnormal brainstem crossing fibers associated with ROBO3 mutations. Neurology 67(3): 519–521
49.Amoiridis G, Tzagournissakis M, Christodoulou P, et al (2006) Patients with horizontal gaze palsy and progressive scoliosis due to ROBO3 E319K mutation have both uncrossed and crossed central nervous system pathways and perform normally on neuropsychological testing. Neurol Neurosurg Psychiatry 77:1047–1053; originally published online 13 Jun 2006
50.Brodsky MC (1991) Platysma-levator synkinesis in congenital third nerve palsy. Arch Ophthalmol 109:620
51.Brodsky MC (1998) Hereditary external ophthalmoplegia, synergistic divergence, jaw winking and oculocutaneous hypopigmentation. Ophthalmology 105:717–725
52.Traboulsi EI (2004) Congenital abnormalities of cranial nerve development: overview, molecular mechanisms, and further evidence of heterogeneity and complexity of syndromes with congenital limitation of eye movements. Trans Am Ophthalmol Soc 102:373–389
53.Traboulsi EI (2007) Congenital cranial dysinnervation disorders and more. J AAPOS 11(3):215–217
54.Astle WF, Rosenbaum AL (1985) Familial congenital fourth cranial nerve palsy. Arch Ophthalmol 103:532–535
55.Jiang Y, Matsuo T, Fuliwara H, et al (2005) ARIX and PHOX2B Polymorphisms in patients with congenital superior oblique muscle palsy. Acta Med Okayama 59(2): 55–62
References 93
56.De Souza-Dias CR, Goldchmitt M (2007) Further considerations about the ophthalmic features of the Möbius sequence, with data of 28 cases. Arq Bras Oftalmol 70(3): 451–457
57.Verzijl HT, van der Zwaag B, Cruysberg JR, et al (2003) Möbius syndrome redefined: a syndrome of rhombencephalic maldevelopment. Neurology 61(3):327–333
58.Von Noorden GK (2002) The history of strabismology. Wayenborgh, Ostende
59.Brown HW (1973) True and simulated superior oblique tendon sheath syndromes. Doc Ophthalmol 34:123–136
60.Wright KW (1999) Brown’s syndrome: diagnosis and management. Trans Am Ophthalmol Soc 47:1023–1107
61.Esser J, Mühlendyck H (2004) Jaensch-Brown-Syndrom. In: Kaufmann H (ed) Strabismus. Georg Thieme, Stuttgart, New York
62.Von Noorden GK, Campos EC (2002) Binocular vision and ocular motility, 6th edn. Mosby, St. Louis
63.Wright KW (ed) (2003) Pediatric ophthalmology and strabismus, 2nd edn. Springer, New York
64.D’Esposito M, Cotticelli L, Caccia-Perugini G, et al (1974) La Pseudoparalisis dell’oblique inferiore. Acta Neurol (Napoli) 29(6):625–658
65.Feric-Seiwerth F, Celic M (1972) Contribution to the knowledge of the superior oblique tendon sheath syndrome. In: Mein J et al (ed) Orthoptics – proceedings of the second international orthoptic congress, Amsterdam 1971. Excerpta Medica, Amsterdam, pp 354–359
66.Papst W, Stein HJ (1969) Zur Ätiologie des Musculus- obliquus-superior-Sehnenscheidensyndroms. Klin Monatsbl Augenheilkd 154:506–518
67.Catford GV, Hart JCD (1971) Superior oblique tendon sheath syndrome. An electromyographical study. Brit J Ophthalmol 55:155–160
68.Clarke WN, Noël LP (1985) Depression in adduction syndrome. Can J Ophthalmol 20:23–28
69.Barton JJ, Intriligator JM (2001) Vertical saccades in superiorobliquepalsyandBrown’ssyndrome.JNeuroophthalmol 21:250–255
70.Wilson ME, Eustis HS, Parks MM (1989) Brown’s syndrome. Surv Ophthalmol 34:153–172
71.Bhola R, Sharma P, Saxena R, et al (2004) Magnetic resonance imaging of an unusual case of Brown’s Syndrome with contralteral superior oblique palsy. J AAPO 8(2): 196–197
72.Castanera de Molina A, Munoz GL (1991) Brown syndrome associated with contralateral superior oblique palsy: a case report. J Pediatr Ophthalmol Strabismus 28: 310–313
73.Clarke WN, Noël LP (1993) Brown’s syndrome with contralateral inferior oblique overaction: a possible mechanism. Can J Ophthalmol 28(5):213–216
74.Berk AT, Erkan D, Sener C, et al (1994) Congenital Brown’s syndrome: clinical and surgical approach.Eur J Ophthalmol 4:138–143
75.Crawford JS, Orton RB, Labow-Daily L (1980) Late results of superior oblique muscle tenotomy in true Brown’s syndrome. Am J Ophthalmol 89:824–829
76.Eustis HS, O’Reilly C, Crawford JS (1987) Management of superior oblique palsy after surgery for true Brown’s syndrome. J Pediatr Ophthalmol Strabismus 24:10–16
77.Hadjadj E, Conrath J, Ridings B, et al (1998) Syndrome de Brown: actualités. J Fr Optalmol 21:276–282
78.Maggi R, Maggi C (2002) Tendon surgery in Brown’s syndrome. J Pediatr Opthalmol Strabismus 39:33–38
79.Parks MM, Eustis HS (1987) Simultaneous superior oblique tenotomy and inferior oblique recession in Brown’s syndrome. Ophthalmology 94:1043–1048
80.Sener EC, Özkan SB, Aribal ME, et al (1996) Evaluation of congenital Brown’s syndrome with magnetic resonance imaging. Eye 10:492–496
81.Von Noorden GK, Olivier P (1982) Superior oblique tenectomy in Brown’s syndrome. Ophthalmology 89:303–309
82.Lobefalo L, Mancini AT, Petitti MT, et al. (1999) A family with autosomal dominant distal arthrogryposis multiplex congenita and Brown syndrome. Ophthalmic Genet 20(4): 233–241
83.Mc Kusick VA (1990). Mendelian inheritance in Man, 9th edn. John Hopkins Univ, Baltimore
84.Paul OT, Hardage LK (1994) The heritability of strabismus. Ophthalmic Genet 15(1):1–18
85.Iannaccone A, McIntosh N, Ciccarelli ML (2002) Familial unilateral Brown syndrome. Ophthalmic Genet 23(3): 175–184
86.Miller MT (1991) Thalidomide embryopathy: a model for the study of congenital incomitant horizontal strabismus. Trans Am Ophthalmol Soc 89:623–674
87.Kida M (ed) (1987) Thalidomide embryopathy in Japan. Kodansha, Tokyo
88.Bhola R, Rosenbaum AL, Ortube MC, et al (2005) Highresolution magnetic imaging demonstrates varied anatomic abnormalities in Brown syndrome. J AAPOS 9(5): 438–448
89.Capasso L, Torre A, Gagliardi V (2001) Spontaneous resolution of congenital bilateral Brown’s Syndrome. Ophthalmologica 215:372–375
90.Gregersen E, Rindziunski E (1993) Brown’s syndrome. Acta Ophthalmol 71:371–376
91.Kaban TJ, Smith K, Orton RB, et al (1993) Natural history of presumed congenital Brown syndrome. Arch Ophthalmol 111:943–946
92.Mühlendyck H (1996) Jaensch-Brown-Syndrom – Ursache und operatives Vorgehen. Klin Monatsbl Augenheilkd 208:37–47
93.Crawford JS (1976) Surgical treatment of true Brown’s syndrome. Am J Ophthalmol 81:289–296
94.White JW (1942) Paralysis of the superior rectus and inferior oblique muscles in the same eye. Arch Ophthalmol 27:366–371
947 Congenital Cranial Dysinnervation Disorders: Facts and Perspectives
95.Olson RJ, Scott WE (1998) Dissociative phenomena in con100. Büttner-Ennever JA (2006) The extraocular motor nuclei:
genital monocular elevation deficiency. J AAPOS 2:72–8
96.Mims JL 3rd (2005) “Double elevator palsy” eye supraducts during stage II general anesthesia supporting hypothesis of
7(supra)nuclear etiology. Binocul Vis Strabismus Q 20(4): 199–204
97.Leigh RJ, Zee DS (2006) The neurology of eye movements, 4th edn. Oxford University, Oxford, New York
98.Bell J A, Fielder A, Viney S (1990) Congenital double elevator palsy in identical twins. J Clin Neuro-ophthalmol 10(1):32–34
99.Verma MJ, Faridi MM (1992) Ocular motility disturbances (Duane retraction syndrome and double elevator palsy) with congenital heart disease, a rare association with Goldenhar syndrome–a case report. Indian J Ophthalmol 40(2):61–62
organization and functional neuroanatomy. In: BüttnerEnnever JA (ed) Neuroanatomy of the oculomotor system. Elsevier, Amsterdam
101.Horn AK, Eberhorn A, Härtig W, et al (2008) Perioculomotor cell groups in monkey and man defined by their histochemical and functional properties: reappraisal of the Edinger-Westphal nucleus. J Comp Neurol 507(3): 1317–1335
102.Sherrington CS (1979) Selected writings of Sir Charles Sherrington. In: Denny-Brown D (ed) Oxford University, Oxford
103.Parks MM, Brown M (1975) Superior oblique tendon sheath syndrome of Brown. Am J Ophthalmol 79(1): 82–86
